Overview

Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol

Status:
Unknown status

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

Summary

Confirm central blood pressure reduction effect of Fimasartan, Valsartan and Atenolol and compare correlation with the measured peripheral (central blood pressure, pulse wave velocity, and flow-mediated dilation) and cerebral blood flow factors (transcranial doppler findings, cerebral blood flow volume) in acute ischemic stroke patients with hypertension.

Phase:

Phase 4

Details

Lead Sponsor:

Ajou University School of Medicine

Collaborator:

Boryung Pharmaceutical Co., Ltd

Treatments:

Atenolol
Valsartan